Skip to main navigation
Skip to search
Skip to main content
United Arab Emirates University Home
Home
Research units
Researchers
Projects
Research output
Datasets
Activities
Press/Media
Prizes
Impacts
Search by expertise, name or affiliation
A novel anti-pancreatic cancer agent, LY293111
Xian Zhong Ding
, Marks S. Talamonti
, Richard H. Bell
, Thomas E. Adrian
Research output
:
Contribution to journal
›
Review article
›
peer-review
42
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A novel anti-pancreatic cancer agent, LY293111'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Effects
50%
Phase I Clinical Trial
25%
Acute Inflammation
25%
BLT2
25%
Early Pancreatic Cancer
25%
Phase II Clinical Trial
25%
Placebo-controlled
25%
Tumor Cell Apoptosis
25%
Major Pathway
25%
BLT1
25%
Precancerous Lesions
25%
Biochemistry, Genetics and Molecular Biology
Arachidonate 5-Lipoxygenase
100%
Leukotriene B4 Receptor
33%
Leukotriene
33%
Medicine and Dentistry
Receptor Subtype
12%
Leukotriene
12%
Mediator
12%
Peroxisome Proliferator Activated Receptor
12%
Prostaglandin Synthase
12%
Leukotriene B4 Receptor Antagonist
12%
Pharmacology, Toxicology and Pharmaceutical Science
Leukotriene B4 Receptor Antagonist
12%